Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly

Recruiting now

Conditions studied: Mild Cognitive Impairment, Mild Dementia

In brief

The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services. The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.

Key facts

Study ID

NCT07504965

Run by

Ludwig-Maximilians - University of Munich

People needed

1020

Starts

2025-07-01

Expected to finish

2027-07-31

Last updated by the study team

2026-04-01

Who can join

Age: 60 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age: Participants must be 60 years or older at the time of consent.
• Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study.
• Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes).
• Consent: Ability to provide informed consent voluntarily.

You may not qualify if…

• Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires.
• Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology.
• Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process.
• These criteria aim to ensure that the study includes participants at risk of early cognitive decline while excluding those for whom the interventions or assessments would not be feasible or relevant.

Where it is running

• Department of Psychiatry and Psychotherapy, LMU Hospital — Munich, Bavaria, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.